Ionis Pharmaceuticals (IONS) Change in Account Payables (2013 - 2026)

Ionis Pharmaceuticals' Change in Account Payables history runs 14 years deep, the most recent figure standing at -$3.1 million for Q1 2026.

• On a quarterly basis, Change in Account Payables rose 88.08% year-over-year to -$3.1 million in Q1 2026; TTM through Mar 2026 was $7.5 million, a 174.85% increase from a year earlier, with the FY2025 full-year figure at -$15.4 million, down 196.06% from the prior year.
• Change in Account Payables slipped to -$3.1 million in Q1 2026 per IONS's latest filing, from $13.8 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $35.2 million in Q4 2024 and bottomed at -$26.0 million in Q1 2025.
• The 5-year median for Change in Account Payables is -$2.2 million (2024), against an average of $396941.2.
• Across the five-year window, Change in Account Payables soared 556.04% in 2023 and slumped 44113.56% in 2025, its largest moves.
• Year by year, Change in Account Payables stood at -$4.5 million in 2022, then surged by 556.04% to $20.6 million in 2023, then surged by 71.06% to $35.2 million in 2024, then tumbled by 60.93% to $13.8 million in 2025, then plunged by 122.5% to -$3.1 million in 2026.
• Per Business Quant, the three latest IONS Change in Account Payables figures stand at -$3.1 million (Q1 2026), $13.8 million (Q4 2025), and -$8.8 million (Q3 2025).